RAYMOND JAMES & ASSOCIATES - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 147 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$5,000
-97.8%
43,718
-68.0%
0.00%
Q3 2018$232,000
-7.6%
136,753
-5.2%
0.00%
Q2 2018$251,000
-5.6%
144,243
-0.7%
0.00%
Q1 2018$266,000
-7.0%
145,243
+13.3%
0.00%
-100.0%
Q4 2017$286,000
-18.5%
128,243
+6.0%
0.00%0.0%
Q3 2017$351,000
+192.5%
120,943
+348.9%
0.00%
Q2 2017$120,000
-61.2%
26,943
-59.3%
0.00%
-100.0%
Q1 2017$309,000
-17.6%
66,242
+7.5%
0.00%0.0%
Q4 2016$375,000
+40.4%
61,615
+27.0%
0.00%0.0%
Q3 2016$267,00048,4990.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders